Veradigm ROA 2012-2022 | MDRX
Current and historical return on assets (ROA) values for Veradigm (MDRX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Veradigm ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2022-12-31 | $-0.09B | $1.84B | -4.69% |
| 2022-09-30 | $0.07B | $2.04B | 3.24% |
| 2022-06-30 | $0.07B | $2.24B | 3.00% |
| 2022-03-31 | $0.15B | $2.44B | 6.27% |
| 2021-12-31 | $0.14B | $2.55B | 5.45% |
| 2021-09-30 | $0.77B | $2.70B | 28.48% |
| 2021-06-30 | $0.76B | $2.87B | 26.32% |
| 2021-03-31 | $0.73B | $3.03B | 23.92% |
| 2020-12-31 | $0.70B | $3.13B | 22.26% |
| 2020-09-30 | $-0.05B | $3.20B | -1.44% |
| 2020-06-30 | $-0.05B | $3.22B | -1.65% |
| 2020-03-31 | $-0.20B | $3.23B | -6.04% |
| 2019-12-31 | $-0.18B | $3.23B | -5.67% |
| 2019-09-30 | $0.21B | $3.22B | 6.55% |
| 2019-06-30 | $0.18B | $3.54B | 5.11% |
| 2019-03-31 | $0.40B | $3.82B | 10.36% |
| 2018-12-31 | $0.36B | $4.11B | 8.87% |
| 2018-09-30 | $0.00B | $4.37B | -0.11% |
| 2018-06-30 | $0.00B | $4.21B | 0.05% |
| 2018-03-31 | $-0.22B | $4.07B | -5.34% |
| 2017-12-31 | $-0.20B | $3.92B | -5.02% |
| 2017-09-30 | $-0.21B | $3.83B | -5.49% |
| 2017-06-30 | $-0.19B | $3.81B | -5.02% |
| 2017-03-31 | $-0.05B | $3.79B | -1.24% |
| 2016-12-31 | $-0.03B | $3.49B | -0.72% |
| 2016-09-30 | $0.00B | $3.21B | -0.06% |
| 2016-06-30 | $0.00B | $2.92B | 0.10% |
| 2016-03-31 | $0.01B | $2.67B | 0.37% |
| 2015-12-31 | $0.00B | $2.64B | -0.08% |
| 2015-09-30 | $-0.02B | $2.59B | -0.77% |
| 2015-06-30 | $-0.04B | $2.56B | -1.60% |
| 2015-03-31 | $-0.06B | $2.53B | -2.21% |
| 2014-12-31 | $-0.07B | $2.57B | -2.61% |
| 2014-09-30 | $-0.09B | $2.61B | -3.30% |
| 2014-06-30 | $-0.11B | $2.62B | -4.16% |
| 2014-03-31 | $-0.11B | $2.64B | -4.31% |
| 2013-12-31 | $-0.11B | $2.64B | -3.98% |
| 2013-09-30 | $-0.11B | $2.57B | -4.20% |
| 2013-06-30 | $-0.05B | $2.51B | -1.99% |
| 2013-03-31 | $-0.02B | $2.47B | -0.77% |
| 2012-12-31 | $0.00B | $2.45B | -0.04% |
| 2012-09-30 | $0.05B | $2.49B | 1.97% |
| 2012-06-30 | $0.06B | $2.49B | 2.37% |
| 2012-03-31 | $0.07B | $2.48B | 2.70% |
| 2011-12-31 | $0.07B | $2.46B | 3.01% |
| 2011-09-30 | $0.04B | $2.44B | 1.73% |
| 2011-06-30 | $0.02B | $2.42B | 0.99% |
| 2011-03-31 | $0.02B | $1.81B | 1.16% |
| 2010-09-30 | $0.03B | $0.87B | 3.80% |
| 2010-06-30 | $0.05B | $0.53B | 9.41% |
| 2010-03-31 | $0.05B | $0.75B | 7.11% |
| 2010-02-28 | $0.05B | $0.75B | 6.31% |
| 2009-09-30 | $0.04B | $0.72B | 5.38% |
| 2009-08-31 | $0.02B | $0.97B | 2.06% |
| 2009-02-28 | $0.02B | $0.64B | 2.50% |
| 2008-11-30 | $0.01B | $0.54B | 0.93% |
| 2008-08-31 | $0.01B | $0.34B | 2.09% |
| 2008-06-30 | $0.01B | $0.34B | 3.58% |
| 2008-03-31 | $0.02B | $0.29B | 7.24% |
| 2008-02-29 | $0.03B | $0.27B | 9.29% |
| 2007-12-31 | $0.02B | $0.39B | 5.33% |
| 2007-11-30 | $0.00B | $0.25B | 1.60% |
| 2007-09-30 | $0.00B | $0.37B | 0.81% |
| 2007-06-30 | $0.00B | $0.37B | 0.82% |
| 2007-05-31 | $0.00B | $0.36B | 0.00% |
| 2007-03-31 | $0.01B | $0.47B | 2.97% |
| 2006-12-31 | $0.01B | $0.46B | 2.39% |
| 2006-09-30 | $0.01B | $0.40B | 2.52% |
| 2006-06-30 | $0.01B | $0.33B | 3.01% |
| 2006-03-31 | $0.01B | $0.27B | 3.33% |
| 2005-12-31 | $0.01B | $0.21B | 4.34% |
| 2005-09-30 | $0.01B | $0.20B | 3.49% |
| 2005-06-30 | $0.01B | $0.20B | 2.55% |
| 2005-03-31 | $0.00B | $0.17B | 2.31% |
| 2004-12-31 | $0.00B | $0.15B | 1.98% |
| 2004-09-30 | $0.00B | $0.13B | 1.53% |
| 2004-06-30 | $0.00B | $0.11B | 0.00% |
| 2004-03-31 | $0.00B | $0.11B | -2.80% |
| 2003-12-31 | $-0.01B | $0.11B | -4.75% |
| 2003-09-30 | $-0.01B | $0.10B | -6.75% |
| 2003-06-30 | $-0.01B | $0.10B | -8.76% |
| 2003-03-31 | $-0.01B | $0.11B | -10.53% |
| 2002-12-31 | $-0.02B | $0.11B | -14.05% |
| 2002-09-30 | $-0.02B | $0.11B | -20.00% |
| 2002-06-30 | $-0.37B | $0.12B | -321.21% |
| 2002-03-31 | $-0.40B | $0.22B | -181.40% |
| 2001-12-31 | $-0.42B | $0.33B | -128.74% |
| 2001-09-30 | $-0.43B | $0.37B | -114.13% |
| 2001-06-30 | $-0.09B | $0.42B | -21.10% |
| 2001-03-31 | $-0.09B | $0.38B | -22.86% |
| 2000-12-31 | $-0.06B | $0.29B | -19.95% |
| 2000-09-30 | $-0.05B | $0.23B | -20.61% |
| 2000-06-30 | $-0.04B | $0.17B | -21.49% |
| 2000-03-31 | $-0.02B | $0.09B | -17.00% |
| 1999-12-31 | $-0.01B | $0.05B | -24.87% |
| 1999-06-30 | $-0.01B | $0.02B | -33.90% |
| 1999-03-31 | $0.00B | $0.01B | -28.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.490B | $0.000B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |